MegaPro Medical’s new MRI contrast agent MPB-2043 has completed the first patient admission in ...
MegaPro Medical’s new MRI contrast agent MPB-2043 has completed the first patient admission in Taiwan
A new nanodrug development company - MegaPro Biomedical Co., Ltd. (hereinafter referred to as "MegaPro", Taiwan OTC Stock Code: 6827) announced today that the company's independently developed new drug MPB-2043, an MRI contrast agent for lymph node staging in patients with head and neck squamous cell carcinoma, has completed the admission of the first domestic patient at National Taiwan ...
MegaPro (6827)’s new drug MPB-2354 issues a press release on WMIS
MegaPro Biomedical’s new cell therapy drug MPB-2354 was announced at the World Society of Molecular Imaging
A new nanodrug development company - MegaPro Biomedical Co., Ltd. (hereinafter referred to as "MegaPro", Taiwan OTC Stock Code: 6827) announced today that Dr. Hsu Yuanhung, vice president of the R&D Department, will head to Oslo, Norway on behalf of MegaPro to participate in the Contrast Media Research Symposium 2024, which is held biannually by the World Molecular Imaging Society ...
MPB-1734: A New Formulation Anti-cancer Drug
The MPB-1734 is an anticancer drug of a new pharmaceutical formulation. After coating commercially available paclitaxel anticancer drugs based on the company’s nanocell technology platform, animal experiments have found that in addition to the qualities of increasing drug dose while ...
MPB-1514 Iron Injection for the Treatment of Iron Deficiency Anemia
◆ What is iron deficiency anemia?
The main causes of iron deficiency anemia (IDA) can be summarized into 4 categories: (1) insufficient iron intake, (2) dysfunctions in iron absorption, (3) increased physiological requirements, and (4) chronic blood loss. The causes of ...
Clinical Trial Platform for New Drugs
New Drug Clinical Trial Platform
Continuing the achievements of the various technology platforms of the R & D center, promoting and integrating clinical trials of new drugs, and mastering the technology required for each new drug development stage while complying with domestic and foreign ...
Immune Cell Calibration Technology Platform
Image Calibration of Immune Cells
With the rapid development of cell biology and molecular biology technology, the research on the technology of using magnetic nanoparticles for cell identification continues to increase. Labeling cells with imaging agents, using MRI to track the distribution, ...